Cargando…

Recurrence of benign paroxysmal positional vertigo: experience in 3042 patients

OBJECTIVES: Benign paroxysmal positional vertigo (BPPV) is a disorder of the inner ear with a high rate of recurrence. Vascular disorders, migraine and autoimmune disorders have been considered facilitating factors for relapsing episodes. Our aim was to assess the role of vascular disorders, migrain...

Descripción completa

Detalles Bibliográficos
Autores principales: Teggi, Roberto, Guidetti, Riccardo, Gatti, Omar, Guidetti, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore Srl 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569667/
https://www.ncbi.nlm.nih.gov/pubmed/34734582
http://dx.doi.org/10.14639/0392-100X-N1233
_version_ 1784594684805382144
author Teggi, Roberto
Guidetti, Riccardo
Gatti, Omar
Guidetti, Giorgio
author_facet Teggi, Roberto
Guidetti, Riccardo
Gatti, Omar
Guidetti, Giorgio
author_sort Teggi, Roberto
collection PubMed
description OBJECTIVES: Benign paroxysmal positional vertigo (BPPV) is a disorder of the inner ear with a high rate of recurrence. Vascular disorders, migraine and autoimmune disorders have been considered facilitating factors for relapsing episodes. Our aim was to assess the role of vascular disorders, migraine and anti-thyroid antibodies in patients with recurrences. METHODS: We retrospectively analysed records of 3042 patients treated for BPPV without other lifetime vertigo. Clinical data included previous vascular disorders of the central nervous system, heart disorders, migraine and recent head trauma. The presence of anti-thyroid autoantibodies was assessed in all patients. RESULTS: Mean age of the first BPPV was 52.8 ± 14.5 years; there were 2339 females (76.9%), while 2048 (67.3%) of patients presented recurrences within two years of follow-up. Previous disorders of the central nervous system, presence of anti-thyroid antibodies, head trauma and migraine showed an association with recurrences. Above all, in subjects having the first BPPV while aged between 40 and 60 years, anti-thyroid antibodies were predictive for recurrences. CONCLUSIONS: Our data are consistent with the hypothesis that anti-thyroid autoantibodies may play a role in recurrences in subjects with initial manifestations between 40 and 60 years.
format Online
Article
Text
id pubmed-8569667
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Pacini Editore Srl
record_format MEDLINE/PubMed
spelling pubmed-85696672021-11-18 Recurrence of benign paroxysmal positional vertigo: experience in 3042 patients Teggi, Roberto Guidetti, Riccardo Gatti, Omar Guidetti, Giorgio Acta Otorhinolaryngol Ital Vestibology OBJECTIVES: Benign paroxysmal positional vertigo (BPPV) is a disorder of the inner ear with a high rate of recurrence. Vascular disorders, migraine and autoimmune disorders have been considered facilitating factors for relapsing episodes. Our aim was to assess the role of vascular disorders, migraine and anti-thyroid antibodies in patients with recurrences. METHODS: We retrospectively analysed records of 3042 patients treated for BPPV without other lifetime vertigo. Clinical data included previous vascular disorders of the central nervous system, heart disorders, migraine and recent head trauma. The presence of anti-thyroid autoantibodies was assessed in all patients. RESULTS: Mean age of the first BPPV was 52.8 ± 14.5 years; there were 2339 females (76.9%), while 2048 (67.3%) of patients presented recurrences within two years of follow-up. Previous disorders of the central nervous system, presence of anti-thyroid antibodies, head trauma and migraine showed an association with recurrences. Above all, in subjects having the first BPPV while aged between 40 and 60 years, anti-thyroid antibodies were predictive for recurrences. CONCLUSIONS: Our data are consistent with the hypothesis that anti-thyroid autoantibodies may play a role in recurrences in subjects with initial manifestations between 40 and 60 years. Pacini Editore Srl 2021-09-14 2021-10 /pmc/articles/PMC8569667/ /pubmed/34734582 http://dx.doi.org/10.14639/0392-100X-N1233 Text en Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International) license. The article can be used by giving appropriate credit and mentioning the license, but only for non-commercial purposes and only in the original version. For further information: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
spellingShingle Vestibology
Teggi, Roberto
Guidetti, Riccardo
Gatti, Omar
Guidetti, Giorgio
Recurrence of benign paroxysmal positional vertigo: experience in 3042 patients
title Recurrence of benign paroxysmal positional vertigo: experience in 3042 patients
title_full Recurrence of benign paroxysmal positional vertigo: experience in 3042 patients
title_fullStr Recurrence of benign paroxysmal positional vertigo: experience in 3042 patients
title_full_unstemmed Recurrence of benign paroxysmal positional vertigo: experience in 3042 patients
title_short Recurrence of benign paroxysmal positional vertigo: experience in 3042 patients
title_sort recurrence of benign paroxysmal positional vertigo: experience in 3042 patients
topic Vestibology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569667/
https://www.ncbi.nlm.nih.gov/pubmed/34734582
http://dx.doi.org/10.14639/0392-100X-N1233
work_keys_str_mv AT teggiroberto recurrenceofbenignparoxysmalpositionalvertigoexperiencein3042patients
AT guidettiriccardo recurrenceofbenignparoxysmalpositionalvertigoexperiencein3042patients
AT gattiomar recurrenceofbenignparoxysmalpositionalvertigoexperiencein3042patients
AT guidettigiorgio recurrenceofbenignparoxysmalpositionalvertigoexperiencein3042patients